This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kiechl, S. Articles by Willeit, J. Search for Related Content PubMed PubMed Citation Articles by Kiechl, S. Articles by Willeit, J. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Carotid Artery Disease Secondhand Smoke Smoking Related Collections Risk Factors Arterial thrombosis Carotid Stenosis Doppler ultrasound, Transcranial Doppler etc. Risk Factors for Stroke

(Stroke. 2002;33:2170.)
© 2002 American Heart Association, Inc.

Original Contributions

Active and Passive Smoking, Chronic Infections, and the Risk of Carotid Atherosclerosis

Prospective Results From the Bruneck Study

Stefan Kiechl, MD; Philipp Werner, MD; Georg Egger, MD; Friedrich Oberhollenzer, MD; Manuel Mayr, MD; Qingbo Xu, MD, PhD; Werner Poewe, MD Johann Willeit, MD

From the Department of Neurology, Innsbruck University Hospital, Innsbruck, Austria (S.K., P.W., W.P., J.W.); Department of Internal Medicine, Bruneck Hospital, Bruneck, Italy (G.E., F.O.); and Department of Cardiological Sciences, St George’s Hospital Medical School, London, UK (M.M., Q.X.).

Correspondence to Dr Stefan Kiechl, Department of Neurology, Innsbruck University Hospital, Anichstrasse 35, A-6020 Innsbruck, Austria. E-mail Stefan.Kiechl{at}uibk.ac.at

Background and Purpose— Susceptibility of the vasculature to the injurious effects of smoking varies substantially, with some smokers developing severe premature atherosclerosis and others remaining free of advanced atheroma until high ages. The present study sought to estimate the contribution of chronic infections to the variability of atherosclerosis severity among smokers.

Methods— In the community-based Bruneck Study, 5-year changes in carotid atherosclerosis were assessed by high-resolution ultrasound. Early atherogenesis was defined by the development of nonstenotic plaques and advanced atherogenesis by the development/progression of vessel stenosis >40%.

Results— The risk of early atherogenesis strongly relied on lifetime smoking exposure and remained elevated long-term after cessation of smoking. Remarkably, current and ex-smokers faced an increased atherosclerosis risk only in the presence of chronic infections (odds ratios [95% CIs], 3.3 [1.8 to 6.2] and 3.4 [1.8 to 6.3]; P<0.001 each), whereas current, past, and nonsmokers without infections did not differ substantially in their estimated risk burden (odds ratios [95% CIs], 1.4 [0.8 to 2.4], 0.9 [0.6 to 1.6], and 1.0 [reference group]). In analogy to first-hand smoking, subjects exposed to environmental tobacco smoke were found to be vulnerable to the manifestation of chronic infection, and only those infected experienced a high atherosclerosis risk. The risk of advanced atherogenesis showed a dose-response relation with the number of daily cigarettes, returned to normal shortly after cessation of smoking, and emerged as independent of infectious illness.

Conclusions— Our study provides the first epidemiological evidence that the proatherogenic effects of cigarette smoking are mediated in part by the chronic infections found in smokers. A better understanding of the vascular pathogenetic mechanisms of smoking may offer novel clues for disease prevention supplementary to the primary goal of achieving long-term abstinence.

Key Words: atherosclerosis • cigarette smoking • infection • inflammation

This article has been cited by other articles:

				S. Ehrlenbach, P. Willeit, S. Kiechl, J. Willeit, M. Reindl, K. Schanda, F. Kronenberg, and A. Brandstatter Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay Int. J. Epidemiol., August 7, 2009; (2009) dyp273v1. [Abstract] [Full Text] [PDF]

				D. M. Mannino, D. Thorn, A. Swensen, and F. Holguin Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Eur. Respir. J., October 1, 2008; 32(4): 962 - 969. [Abstract] [Full Text] [PDF]

				L. Moro, C. Pedone, S. Scarlata, V. Malafarina, F. Fimognari, and R. Antonelli-Incalzi Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease Angiology, July 1, 2008; 59(3): 357 - 364. [Abstract] [PDF]

				C-G. Lofdahl, D. S. Postma, N. B. Pride, J. Boe, and A. Thoren Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD Eur. Respir. J., June 1, 2007; 29(6): 1115 - 1119. [Abstract] [Full Text] [PDF]

				H. S. Markus, R. Labrum, S. Bevan, M. Reindl, G. Egger, C. J. Wiedermann, Q. Xu, S. Kiechl, and J. Willeit Genetic and Acquired Inflammatory Conditions Are Synergistically Associated With Early Carotid Atherosclerosis Stroke, September 1, 2006; 37(9): 2253 - 2259. [Abstract] [Full Text] [PDF]

				M. Knoflach, S. Kiechl, A. Mayr, J. Willeit, W. Poewe, and G. Wick Allergic Rhinitis, Asthma, and Atherosclerosis in the Bruneck and ARMY Studies Arch Intern Med, November 28, 2005; 165(21): 2521 - 2526. [Abstract] [Full Text] [PDF]

				J. Barnoya and S. A. Glantz Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking Circulation, May 24, 2005; 111(20): 2684 - 2698. [Abstract] [Full Text] [PDF]

				P. K. MacCallum Markers of Hemostasis and Systemic Inflammation in Heart Disease and Atherosclerosis in Smokers Proceedings of the ATS, April 1, 2005; 2(1): 34 - 43. [Abstract] [Full Text] [PDF]

				M. Furtner, S. Kiechl, A. Mair, K. Seppi, S. Weger, F. Oberhollenzer, W. Poewe, and J. Willeit Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population Eur. Heart J., February 1, 2005; 26(3): 279 - 287. [Abstract] [Full Text] [PDF]

				P. Lind, G. Engstrom, L. Stavenow, L. Janzon, F. Lindgarde, and B. Hedblad Risk of Myocardial Infarction and Stroke in Smokers Is Related to Plasma Levels of Inflammation-Sensitive Proteins Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 577 - 582. [Abstract] [Full Text] [PDF]

				E. G. Butchart, A. Ionescu, N. Payne, J. Giddings, G. L. Grunkemeier, and A. G. Fraser A New Scoring System to Determine Thromboembolic Risk After Heart Valve Replacement Circulation, September 9, 2003; 108(90101): II-68 - 74. [Abstract] [Full Text] [PDF]

				S. Tsiara, M. Elisaf, and D. P. Mikhailidis Influence of Smoking on Predictors of Vascular Disease Angiology, September 1, 2003; 54(5): 507 - 530. [Abstract] [PDF]

				M. Frohlich, M. Sund, H. Lowel, A. Imhof, A. Hoffmeister, and W. Koenig Independent association of various smoking characteristics with markers of systemic inflammation in men: Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95) Eur. Heart J., July 2, 2003; 24(14): 1365 - 1372. [Abstract] [Full Text] [PDF]